Antiproliferative actions of growth hormone-releasing hormone antagonists on MiaPaCa-2 human pancreatic cancer cells involve cAMP independent pathways

Z. Rékási, Jozsef L. Varga, Andrew V. Schally, Artur Plonowski, Gabor Halmos, B. Csernus, Patricia Armatis, Kate Groot

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

We evaluated the effects of GHRH antagonists on the proliferation of MiaPaCa-2 human pancreatic cancer cells and cAMP signaling in vitro. GHRH antagonists inhibited the proliferation of MiaPaCa-2 cells in vitro in a dose-dependent way and caused a significant elevation in cAMP production. In a superfusion system, short-term exposure of the cells to GHRH antagonists evoked an acute, dose-dependent release of cAMP into the medium. Native GHRH, which stimulates cAMP efflux from pituitary at nanomolar doses, did not influence cAMP release from cultured or superfused MiaPaCa-2 cells even at 10-30 μM. VIP, PACAP, secretin and glucagon also did not influence cell proliferation or cAMP production. Adenylate cyclase activator forskolin (FSK) caused a greater cAMP response, but a smaller antiproliferative effect than GHRH antagonists. Combined treatment with FSK and GHRH antagonist JV-1-38 potentiated the cAMP-inducing effect of FSK, but did not produce a greater inhibition of cell proliferation than JV-1-38 alone. A selective accumulation of radiolabeled GHRH antagonist [125I]JV-1-42 in vivo in MiaPaCa-2 carcinoma xenografted into nude mice was also observed. In conclusion, second messengers other than cAMP participate in the signal transduction pathways of GHRH analogs mediated by tumoral GHRH receptors.

Original languageEnglish
Pages (from-to)879-886
Number of pages8
JournalPeptides
Volume22
Issue number6
DOIs
Publication statusPublished - 2001

Fingerprint

Hormone Antagonists
Growth Hormone-Releasing Hormone
Colforsin
Pancreatic Neoplasms
Cells
Cell proliferation
Pituitary Adenylate Cyclase-Activating Polypeptide
Signal transduction
Secretin
Cell Proliferation
Second Messenger Systems
Glucagon
Adenylyl Cyclases
Nude Mice
Signal Transduction
Carcinoma
JV 1-38
In Vitro Techniques

Keywords

  • Anticancer drugs
  • cAMP
  • GHRH antagonists
  • Signal transduction
  • Tumoral GHRH receptors

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology
  • Cellular and Molecular Neuroscience

Cite this

Antiproliferative actions of growth hormone-releasing hormone antagonists on MiaPaCa-2 human pancreatic cancer cells involve cAMP independent pathways. / Rékási, Z.; Varga, Jozsef L.; Schally, Andrew V.; Plonowski, Artur; Halmos, Gabor; Csernus, B.; Armatis, Patricia; Groot, Kate.

In: Peptides, Vol. 22, No. 6, 2001, p. 879-886.

Research output: Contribution to journalArticle

Rékási, Z. ; Varga, Jozsef L. ; Schally, Andrew V. ; Plonowski, Artur ; Halmos, Gabor ; Csernus, B. ; Armatis, Patricia ; Groot, Kate. / Antiproliferative actions of growth hormone-releasing hormone antagonists on MiaPaCa-2 human pancreatic cancer cells involve cAMP independent pathways. In: Peptides. 2001 ; Vol. 22, No. 6. pp. 879-886.
@article{3d8ed2f954ee42118e3b3d16bbdf2bee,
title = "Antiproliferative actions of growth hormone-releasing hormone antagonists on MiaPaCa-2 human pancreatic cancer cells involve cAMP independent pathways",
abstract = "We evaluated the effects of GHRH antagonists on the proliferation of MiaPaCa-2 human pancreatic cancer cells and cAMP signaling in vitro. GHRH antagonists inhibited the proliferation of MiaPaCa-2 cells in vitro in a dose-dependent way and caused a significant elevation in cAMP production. In a superfusion system, short-term exposure of the cells to GHRH antagonists evoked an acute, dose-dependent release of cAMP into the medium. Native GHRH, which stimulates cAMP efflux from pituitary at nanomolar doses, did not influence cAMP release from cultured or superfused MiaPaCa-2 cells even at 10-30 μM. VIP, PACAP, secretin and glucagon also did not influence cell proliferation or cAMP production. Adenylate cyclase activator forskolin (FSK) caused a greater cAMP response, but a smaller antiproliferative effect than GHRH antagonists. Combined treatment with FSK and GHRH antagonist JV-1-38 potentiated the cAMP-inducing effect of FSK, but did not produce a greater inhibition of cell proliferation than JV-1-38 alone. A selective accumulation of radiolabeled GHRH antagonist [125I]JV-1-42 in vivo in MiaPaCa-2 carcinoma xenografted into nude mice was also observed. In conclusion, second messengers other than cAMP participate in the signal transduction pathways of GHRH analogs mediated by tumoral GHRH receptors.",
keywords = "Anticancer drugs, cAMP, GHRH antagonists, Signal transduction, Tumoral GHRH receptors",
author = "Z. R{\'e}k{\'a}si and Varga, {Jozsef L.} and Schally, {Andrew V.} and Artur Plonowski and Gabor Halmos and B. Csernus and Patricia Armatis and Kate Groot",
year = "2001",
doi = "10.1016/S0196-9781(01)00413-2",
language = "English",
volume = "22",
pages = "879--886",
journal = "Peptides",
issn = "0196-9781",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Antiproliferative actions of growth hormone-releasing hormone antagonists on MiaPaCa-2 human pancreatic cancer cells involve cAMP independent pathways

AU - Rékási, Z.

AU - Varga, Jozsef L.

AU - Schally, Andrew V.

AU - Plonowski, Artur

AU - Halmos, Gabor

AU - Csernus, B.

AU - Armatis, Patricia

AU - Groot, Kate

PY - 2001

Y1 - 2001

N2 - We evaluated the effects of GHRH antagonists on the proliferation of MiaPaCa-2 human pancreatic cancer cells and cAMP signaling in vitro. GHRH antagonists inhibited the proliferation of MiaPaCa-2 cells in vitro in a dose-dependent way and caused a significant elevation in cAMP production. In a superfusion system, short-term exposure of the cells to GHRH antagonists evoked an acute, dose-dependent release of cAMP into the medium. Native GHRH, which stimulates cAMP efflux from pituitary at nanomolar doses, did not influence cAMP release from cultured or superfused MiaPaCa-2 cells even at 10-30 μM. VIP, PACAP, secretin and glucagon also did not influence cell proliferation or cAMP production. Adenylate cyclase activator forskolin (FSK) caused a greater cAMP response, but a smaller antiproliferative effect than GHRH antagonists. Combined treatment with FSK and GHRH antagonist JV-1-38 potentiated the cAMP-inducing effect of FSK, but did not produce a greater inhibition of cell proliferation than JV-1-38 alone. A selective accumulation of radiolabeled GHRH antagonist [125I]JV-1-42 in vivo in MiaPaCa-2 carcinoma xenografted into nude mice was also observed. In conclusion, second messengers other than cAMP participate in the signal transduction pathways of GHRH analogs mediated by tumoral GHRH receptors.

AB - We evaluated the effects of GHRH antagonists on the proliferation of MiaPaCa-2 human pancreatic cancer cells and cAMP signaling in vitro. GHRH antagonists inhibited the proliferation of MiaPaCa-2 cells in vitro in a dose-dependent way and caused a significant elevation in cAMP production. In a superfusion system, short-term exposure of the cells to GHRH antagonists evoked an acute, dose-dependent release of cAMP into the medium. Native GHRH, which stimulates cAMP efflux from pituitary at nanomolar doses, did not influence cAMP release from cultured or superfused MiaPaCa-2 cells even at 10-30 μM. VIP, PACAP, secretin and glucagon also did not influence cell proliferation or cAMP production. Adenylate cyclase activator forskolin (FSK) caused a greater cAMP response, but a smaller antiproliferative effect than GHRH antagonists. Combined treatment with FSK and GHRH antagonist JV-1-38 potentiated the cAMP-inducing effect of FSK, but did not produce a greater inhibition of cell proliferation than JV-1-38 alone. A selective accumulation of radiolabeled GHRH antagonist [125I]JV-1-42 in vivo in MiaPaCa-2 carcinoma xenografted into nude mice was also observed. In conclusion, second messengers other than cAMP participate in the signal transduction pathways of GHRH analogs mediated by tumoral GHRH receptors.

KW - Anticancer drugs

KW - cAMP

KW - GHRH antagonists

KW - Signal transduction

KW - Tumoral GHRH receptors

UR - http://www.scopus.com/inward/record.url?scp=0035007344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035007344&partnerID=8YFLogxK

U2 - 10.1016/S0196-9781(01)00413-2

DO - 10.1016/S0196-9781(01)00413-2

M3 - Article

C2 - 11390017

AN - SCOPUS:0035007344

VL - 22

SP - 879

EP - 886

JO - Peptides

JF - Peptides

SN - 0196-9781

IS - 6

ER -